Home / Denmark / GN Store Nord A/S
GN Store Nord A/S
Short position disclosed on May 28, 2026.
4.81% of the capital sold short
5 disclosing funds
713 disclosures on record
DK0010272632 ISIN code
Evolution of the disclosed total
0%2%4%6%
Oct 2025Jan 2026Apr 2026Jul 2026
February 28, 2014 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| AKO Capital LLP | 1.30% | new | April 22, 2026 | |
| Atalan Capital Partners, LP | 1.13% | new | October 2, 2025 | |
| Millennium International Management LP | 0.97% | new | May 28, 2026 | |
| Capital Fund Management | 0.90% | new | May 27, 2026 | |
| Citadel Advisors LLC | 0.51% | new | May 22, 2026 |
On the other side: the funds that hold GN Store Nord A/S Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| June 24, 2015 | Naya Management LLP | 0.66% | June 24, 2015 |
| June 22, 2015 | Naya Management LLP | 0.55% | June 22, 2015 |
| June 11, 2015 | AKO Capital LLP | 1.11% | June 11, 2015 |
| June 10, 2015 | AKO Capital LLP | 1.07% | June 10, 2015 |
| June 9, 2015 | AKO Capital LLP | 0.90% | June 9, 2015 |
| February 6, 2015 | WorldQuant LLC | 0.49% | February 6, 2015 |
| January 7, 2015 | WorldQuant LLC | 0.50% | January 7, 2015 |
| December 22, 2014 | WorldQuant LLC | 0.49% | December 22, 2014 |
| December 18, 2014 | WorldQuant LLC | 0.50% | December 18, 2014 |
| March 25, 2014 | Marshall Wace LLP | 0.48% | March 25, 2014 |
| March 13, 2014 | Marshall Wace LLP | 0.58% | March 13, 2014 |
| March 5, 2014 | Marshall Wace LLP | 0.60% | March 5, 2014 |
| February 28, 2014 | Marshall Wace LLP | 0.51% | February 28, 2014 |
Other companies sold short in Denmark
- Zealand Pharma A/S 6.75% of the capital sold short
- Ambu A/S 4.00% of the capital sold short
- Pandora A/S 2.25% of the capital sold short
- Carlsberg A/S 1.90% of the capital sold short
- Demant A/S 1.89% of the capital sold short
- Netcompany Group A/S 1.58% of the capital sold short
- Aquaporin A/S 1.51% of the capital sold short
- Matas A/S 1.28% of the capital sold short
- Noble Corporation Plc 1.17% of the capital sold short
- Novozymes A/S 1.00% of the capital sold short
- ChemoMetec A/S 0.92% of the capital sold short
- Coloplast A/S 0.79% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, GN Store Nord A/S, source Finanstilsynet, data as at May 28, 2026, https://www.quivad.com/action/gn-store-nord-a-s?page=15